CDKN2A and astrocytoma (excluding glioblastoma): This classification suggests that, in theory, there could be three subgroups of IDHm astrocytoma WHO grade 4; those exhibiting only molecular WHO grade 4 criteria (CDKN2A/B deletion), those with only morphological WHO grade 4 criteria and those presenting with combined criteria.